U.S. Formulation Development Outsourcing Market · GlobeNewswire Inc. Dublin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The "United States Formulation Development Outsourcing Market Report by Service, ...
This new Aramchol formulation was co-developed by Galmed and Barcode Nanotech, based on Barcode Nanotech's unique and proprietary platform which enables simultaneous screening of hundreds of different ...
Formulation Development Outsourcing Market · GlobeNewswire Inc. Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Pharma Formulation Development Outsourcing Market Size and Growth Trends and Companies ...
CRDMOs offer a continuum of services from early discovery to clinical manufacturing, addressing solubility and stability challenges in NCE development. Advanced technologies like spray drying and ...
A biotech company based in Spain says that new formulations are allowing the organization to deliver larger molecules straight to the pulmonary system. RidNova Pharmaceuticals says it’s using ...
The global formulation development outsourcing market is on a significant growth trajectory, with a projected compound annual growth rate (CAGR) of 7.2% over the next decade. Valued at USD 33.23 ...
eTheRNA Manufacturing, a specialist CDMO member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and ...
The global formulation development outsourcing industry was estimated at $22.5 billion in 2021, and is anticipated to hit $51.9 billion by 2031, registering a CAGR of 9% from 2022 to 2031. The ...
Suzanne Jansen, MSc, PharmD, ICON, says early-phase clinical success depends on flexible, simple formulations that support wide dose ranges, matching placebos, and robust stability. Formulations are ...
Hyderabad, India: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage biopharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results